Markets:

Overview

News

Currencies

International

Treasuries

Atai Beckley N.V - Common Shares (NQ:ATAI)

3.800 +0.140 (+3.83%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 21, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Atai Beckley N.V - Common Shares

< Previous 1 2

...

18 19 20 21 22 23 24 25 26

...

29 30 Next >

Aurora Sky Is No More, Stablecoins Melt Down and SAFE Banking Receives Another Boost ↗

May 17, 2022

In this week’s Trade To Black Podcast, TDR Founder Shadd Dales, lead financial writer Benjamin A. Smith and millennial entrepreneur Anthony Varrell talk macro market, crypto, the dangers of algorithmic...

Via Benzinga

Psyched: Compass, Atai And MindMed Release Q1 Earnings, Phase 3 MDMA Trial Closer To Completion, Enveric Splits Into Two Companies ↗

May 17, 2022

The psychedelics space got a new glimpse at the financials of some of its heavy hitters with the release of earnings reports for the first quarter of 2022.

Via Benzinga

Psychedelic Stock Gainers And Losers From May 16, 2022 ↗

May 16, 2022

GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 25.00% at $0.22

Via Benzinga

EXCLUSIVE: Atai Life Sciences Posts Earnings for Q1 2022, Advancing Key Milestones In Psychedelic Drug Development ↗

May 16, 2022

Atai Life Sciences (NASDAQ: ATAI), a biotech company leading the development of psychedelic compounds for mental health purposes, issued its financial report for the first quarter of the year, ending...

Via Benzinga

Earnings Scheduled For May 16, 2022 ↗

May 16, 2022

Companies Reporting Before The Bell • AcelRx Pharmaceuticals (NASDAQ:ACRX) is estimated to report quarterly loss at $0.06 per share on revenue of $550.00 thousand.

Via Benzinga

Psychedelic Compounds-Based Stocks Index Imploding ↗

May 14, 2022

Our index of Psychedelic Compounds-Based Drug Stocks tracks clinical-stage startups still in R&D is down 60% YTD; -78% from its 2021 high.

Via Talk Markets

Field Trip Health, ATAI Life Sciences Among Top Psychedelic Movers Of Today ↗

May 13, 2022

GAINERS: Field Trip Health (NASDAQ:FTRP) shares closed up 20.93% at $0.94

Via Benzinga

Psychedelic Stock Gainers And Losers From May 12, 2022 ↗

May 12, 2022

GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 4.44% at $7.06

Via Benzinga

Psychedelic Stock Gainers And Losers From May 11, 2022 ↗

May 11, 2022

GAINERS: Intelgenx Technologies (OTC:IGXT) shares closed up 1.37% at $0.27 LOSERS:

Via Benzinga

Intelgenx Technologies, Compass Pathways Among Top Psychedelic Movers Of Today ↗

May 10, 2022

GAINERS: Intelgenx Technologies (OTC:IGXT) shares closed up 16.68% at $0.26

Via Benzinga

American Billionaire Entrepreneurs Bet Millions on Psychedelics

May 10, 2022

FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – May 10, 2022 – Billionaire Bob Parsons, the founder of GoDaddy, believes psychedelics can heal trauma. The Marine infantryman...

Via FinancialNewsMedia

Psychedelic Stock Gainers And Losers From May 9, 2022 ↗

May 09, 2022

GAINERS: LOSERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed down 13.47% at $3.34

Via Benzinga

Psychedelic Stocks Continue To Decline In May ↗

May 08, 2022

The 10 companies in our Psychedelic Compounds-Based Drug Stocks Index are clinical-stage startups still in the product research and development of novel compounds with no products and no revenue.

Via Talk Markets

TripAdvisor, Field Trip Health Among Top Psychedelic Movers Of Today ↗

May 06, 2022

GAINERS: Small Pharma (OTC:DMTTF) shares closed up 9.40% at $0.16

Via Benzinga

GH Research, Intelgenx Technologies Among Top Psychedelic Movers Of Today ↗

May 05, 2022

GAINERS: TripAdvisor (NASDAQ:TRIP) shares closed up 5.09% at $25.80 LOSERS:

Via Benzinga

Intelgenx Technologies, Field Trip Health Among Top Psychedelic Movers Of Today ↗

May 04, 2022

GAINERS: Intelgenx Technologies (OTC:IGXT) shares closed up 13.21% at $0.30

Via Benzinga

Allied, ATAI Life Sciences Among Top Psychedelic Movers Of Today ↗

May 03, 2022

GAINERS: Allied (OTC:ALID) shares closed up 5.27% at $0.76

Via Benzinga

Psyched: Elon Musk Praises Psychedelics Over Antidepressants, Field Trip To Split In Two, Colorado MDMA Bill Moves Forward ↗

May 02, 2022

The world’s richest man gave another public nod to psychedelics medicine in favor of traditional mental health solutions.

Via Benzinga

Compass Pathways, Small Pharma Among Top Psychedelic Movers Of Today ↗

May 02, 2022

GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 8.17% at $9.80

Via Benzinga

Cathie Wood Finds Elon Musk's Comment On Psychedelics, Ketamine An 'Interesting Thesis' For This Stock ↗

May 02, 2022

Via Benzinga

Field Trip Health, Revive Therapeutics Among Top Psychedelic Movers Of Today ↗

April 29, 2022

GAINERS: Cybin (AMEX:CYBN) shares closed up 3.67% at $0.57 LOSERS:

Via Benzinga

ATAI Life Sciences Present A "New Recipe For Success" At The Psychedelic Capital Conference ↗

April 29, 2022

This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.

Via Benzinga

Psychedelic Stock Gainers And Losers From April 28, 2022 ↗

April 28, 2022

GAINERS: Field Trip Health (NASDAQ:FTRP) shares closed up 4.35% at $1.20

Via Benzinga

Psychedelic Stock Gainers And Losers From April 27, 2022 ↗

April 27, 2022

GAINERS: Intelgenx Technologies (OTC:IGXT) shares closed up 3.77% at $0.28

Via Benzinga

Psychedelic Stock Gainers And Losers From April 26, 2022 ↗

April 26, 2022

GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 3.61% at $0.29

Via Benzinga

ATAI Life Sciences, Compass Pathways Among Top Psychedelic Movers Of Today ↗

April 25, 2022

GAINERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed up 3.97% at $4.97

Via Benzinga

Psyched: Big Pharma's Sanofi Enters Psychedelics Space, DNA From 80 Psilocybe Mushrooms Published Online, Maine Psychedelics Bill Shelved ↗

April 25, 2022

Benzinga’s first-ever Psychedelics Capital Conference was a colossal success. Over 600 investors, policymakers, industry executives and thought leaders gathered at the Fontainebleau Hotel in Miami...

Via Benzinga

Missed The Benzinga Psychedelics Capital Conference? Check Out Full Recording And Exclusive Coverage ↗

April 25, 2022

Via Benzinga

Big Pharma's Sanofi Enters Licencing Agreement With Private Psychedelics Company Terran ↗

April 25, 2022

Terran Biosciences is slowly but surely finding its place in the psychedelics industry.

Via Benzinga

Shark Tank's Kevin O'Leary Says Twitter's Biggest Risk Is If Elon Musk 'Goes Away' ↗

April 24, 2022

Shark Tank investor Kevin O’Leary hopes that Tesla Inc (NASDAQ: TSLA) CEO Elon Musk will be successful in his attempt to take over Twitter (NYSE:

Via Benzinga

< Previous 1 2

...

18 19 20 21 22 23 24 25 26

...

29 30 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Atai Beckley N.V - Common Shares (NQ:ATAI)

All News about Atai Beckley N.V - Common Shares

Starting at $3.75/week.

Subscribe Today